Sandoz

125 articles with Sandoz

• Sandoz Proposed Biosimilar Rituximab Accepted For Review By The FDA

  9/12/2017

• Sandoz Expands Partnership With World Child Cancer, To Help Children Access Treatment In Four Developing Countries

  7/25/2017

• Amphastar Announces Jury Verdict In Patent Litigation Against Momenta And Sandoz

  7/24/2017

• FDA Accepts Sandoz Regulatory Submission For A Generic Version Of Advair Diskus

  6/19/2017

• DURECT's Collaboration With Sandoz Clears HSR Review And Is Effective

  6/19/2017

• Apobiologix Applauds Supreme Court Decision In Sandoz Biosimilar Case

  6/13/2017

• Sandoz Proposed Biosimilars Adalimumab And Infliximab Accepted For Regulatory Review By The EMA

  5/31/2017

• Sandoz Proposed Biosimilars Rituximab And Etanercept Recommended For Approval In Europe*

  4/24/2017

• New Data Demonstrate Sandoz Proposed Biosimilar Adalimumab Has Equivalent Efficacy To Reference Medicine

  3/6/2017

• Sandoz Launches Generic Version Of Emend Capsules

  1/4/2017

• Sandoz To Donate Up To USD 10 Million Of High-Quality Generic Medicines Annually To Americares To Increase Access To Medicines

  11/22/2016

• Former Sandoz CEO Joins Supervisory Board Of LEUKOCARE

  7/15/2016

• Ex Novartis AG-Sandoz CEO to Lead AAT Research’s Global Expansion

  4/7/2016

• Novartis AG's Sandoz to Consolidate Two N.Y. Manufacturing Sites, No Job Losses Expected

  3/10/2016

• United Therapeutics Announces Settlement Of Patent Litigation With Sandoz

  9/30/2015

• Novartis AG’s Sandoz Shuttered Three Plants, Lays Off 720

  7/24/2015

• Novartis AG's Sandoz Bags Approval for First Biosimilar to be Sold in the U.S.

  3/9/2015

• Novartis AG Release: FDA Approves First Biosimilar Zarxi (Filgrastim-Sndz) From Sandoz

  3/6/2015

• Phase 3 Data Shows Sandoz, Inc.'s Investigational Biosimilar Filgrastim Has Similar Safety And Efficacy As Amgen's NEUPOGEN®

  12/8/2014

• Apricus Biosciences Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Belgium By Sandoz, Inc.

  11/3/2014